SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology: The Patenting of DNA
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (17)6/28/1999 10:58:00 PM
From: RCMac  Read Replies (2) of 37
 
PB,
>>imagine that the drug developer used several "tools" (a gene from INCY, a small molecule library from ARQL, some patented trick to improve oral availability, etc, etc); this is where these guys start whining about "royalty stacking." . . . . . at some point the tool user may determine that is not worth pursuing a risky drug development project if they anticipate significant erosion of margins due to royalties, if and when they reach the market.<<

For some further perspective on the possible stalemate where there are overlapping patents and the parties holding the various fragments cannot amicably agree on licensing terms, note this Science article by a couple of law faculty: sciencemag.org

--RCM
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News